ESPR Historical Earnings image   This ESPR historical earnings page last updated 11/3/2022
ESPR Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/1/20220.02B
Q2 20228/2/20220.02B
Q1 20225/3/20220.02B
Q4 20212/22/20220.02B
Q3 202111/2/20210.01B
Q2 20218/3/20210.04B
Q1 20215/4/20210.01B
Q4 20202/23/20210.01B
Q3 202011/2/20200.00B
Q2 20208/10/20200.21B
Q1 20205/6/20200.00B
Q4 20192/27/20200.00B
Q3 201911/6/20190.00B
Q2 20198/8/20190.00B
Q1 20195/8/20190.15B
Q4 20182/28/2019NA
Q3 201811/1/2018NA
Q2 20188/2/2018NA
Q1 20185/2/2018NA
Q4 20172/20/2018NA
Q3 201711/7/2017NA
Q2 20178/8/2017NA
Q1 20175/4/2017NA
Q4 20162/22/2017NA
Q3 201611/3/2016NA
Q2 20168/4/2016NA
Q1 20165/4/2016NA
Q4 20152/25/2016NA
Q3 201511/5/2015NA
Q2 20158/6/2015NA
Q1 20155/7/2015NA
Q4 20143/5/2015NA
Q3 201411/10/2014NA
Q2 20148/12/2014NA
Q1 20145/12/2014NA
Q4 20133/5/2014NA
Q3 201311/6/2013NA
Q2 20138/12/2013NA
Q1 20136/12/2013NA
ESPR Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202211/1/2022-0.810
Q2 20228/2/2022-1.050
Q1 20225/3/2022-0.930
Q4 20212/22/2022-1.770
Q3 202111/2/2021-2.620
Q2 20218/3/2021-1.670
Q1 20215/4/2021-3.500
Q4 20202/23/2021-3.890
Q3 202011/2/2020-3.070
Q2 20208/10/20204.320
Q1 20205/6/2020-2.840
Q4 20192/27/2020-2.260
Q3 201911/6/2019-2.520
Q2 20198/8/2019-2.010
Q1 20195/8/20193.070
Q4 20182/28/2019-2.24
Q3 201811/1/2018-1.86
Q2 20188/2/2018-1.71
Q1 20185/2/2018-1.73
Q4 20172/20/2018-1.44
Q3 201711/7/2017-1.86
Q2 20178/8/2017-1.92
Q1 20175/4/2017-1.8
Q4 20162/22/2017-1.29
Q3 201611/3/2016-0.77
Q2 20168/4/2016-0.62
Q1 20165/4/2016-0.65
Q4 20152/25/2016-0.58
Q3 201511/5/2015-0.57
Q2 20158/6/2015-0.55
Q1 20155/7/2015-0.56
Q4 20143/5/2015-0.49
Q3 201411/10/2014-0.64
Q2 20148/12/2014-0.6
Q1 20145/12/2014-0.51
Q4 20133/5/2014-0.63
Q3 201311/6/2013-0.34
Q2 20138/12/2013-19.82
Q1 20136/12/2013-0.54
Quotes delayed 20 minutes

Email EnvelopeFree ESPR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Esperion Therapeutics (ESPR) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ETNB Historical Earnings
ETON Historical Earnings
ETTX Historical Earnings
EVFM Historical Earnings
EVLO Historical Earnings
EVOK Historical Earnings
EW Historical Earnings
EWTX Historical Earnings
EXAS Historical Earnings
EXEL Historical Earnings
What was the record high ESPR historical earnings result?
In terms of earnings or revenue, what is the best ESPR historical earnings result that Esperion Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest ESPR historical earnings result was set in Q2 2020, when Esperion Therapeutics posted results of 4.320/share. The most successful revenue quarter within our data set was Q2 2020 when Esperion Therapeutics reported revenue of 0.21B.

What was the lowest Esperion Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest ESPR has reported, and when?

✔️Accepted answer: Within our data set, the lowest ESPR historical earnings result was set in Q2 2013, when Esperion Therapeutics posted results of -19.82/share. The smallest revenue quarter within our data set was Q4 2018 when Esperion Therapeutics reported revenue of NA.

On this page we presented the ESPR historical earnings date information for Esperion Therapeutics. Reviewing that ESPR Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2020, when ESPR posted gaap of 4.320/share. Meanwhile the lowest ESPR historical earnings result was in Q2 2013, when ESPR posted gaap of -19.82/share. Moving to Esperion Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2020 when ESPR reported 0.21B in revenue, while the smallest revenue quarter was Q4 2018 when ESPR reported NA in revenue.

For self directed investors doing their due diligence on ESPR or any other given stock, their research can benefit from looking into all of the Esperion Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Esperion Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for ESPR. Thanks for visiting, and the next time you need to research ESPR historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Top Ten Hedge Funds Holding WST, Top Ten Hedge Funds Holding FENC, Enphase Energy RSI.

 

ESPR Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.